nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—Alopecia reversible—Mesalazine—Crohn's disease	0.138	0.154	CcSEcCtD
Penbutolol—Ache—Mesalazine—Crohn's disease	0.0679	0.0757	CcSEcCtD
Penbutolol—Throat sore—Mesalazine—Crohn's disease	0.0435	0.0485	CcSEcCtD
Penbutolol—Oropharyngeal discomfort—Mesalazine—Crohn's disease	0.0431	0.0481	CcSEcCtD
Penbutolol—Rash erythematous—Mesalazine—Crohn's disease	0.0409	0.0456	CcSEcCtD
Penbutolol—Oropharyngeal pain—Mesalazine—Crohn's disease	0.0344	0.0384	CcSEcCtD
Penbutolol—Alopecia—Mercaptopurine—Crohn's disease	0.0256	0.0286	CcSEcCtD
Penbutolol—Disorientation—Mesalazine—Crohn's disease	0.0254	0.0284	CcSEcCtD
Penbutolol—Affect lability—Mesalazine—Crohn's disease	0.0224	0.025	CcSEcCtD
Penbutolol—Mood swings—Mesalazine—Crohn's disease	0.0215	0.024	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.0183	0.0204	CcSEcCtD
Penbutolol—Agranulocytosis—Azathioprine—Crohn's disease	0.018	0.02	CcSEcCtD
Penbutolol—Depression—Mesalazine—Crohn's disease	0.0175	0.0195	CcSEcCtD
Penbutolol—Sweating—Mesalazine—Crohn's disease	0.0168	0.0187	CcSEcCtD
Penbutolol—Agranulocytosis—Mesalazine—Crohn's disease	0.0164	0.0182	CcSEcCtD
Penbutolol—Body temperature increased—Mercaptopurine—Crohn's disease	0.0163	0.0182	CcSEcCtD
Penbutolol—Alopecia—Azathioprine—Crohn's disease	0.0153	0.017	CcSEcCtD
Penbutolol—Diarrhoea—Mercaptopurine—Crohn's disease	0.0141	0.0157	CcSEcCtD
Penbutolol—Alopecia—Mesalazine—Crohn's disease	0.0139	0.0155	CcSEcCtD
Penbutolol—Amnesia—Prednisone—Crohn's disease	0.0128	0.0143	CcSEcCtD
Penbutolol—Nausea—Mercaptopurine—Crohn's disease	0.0122	0.0136	CcSEcCtD
Penbutolol—Cough—Mesalazine—Crohn's disease	0.012	0.0133	CcSEcCtD
Penbutolol—Affect lability—Prednisone—Crohn's disease	0.0118	0.0132	CcSEcCtD
Penbutolol—Mood swings—Prednisone—Crohn's disease	0.0114	0.0127	CcSEcCtD
Penbutolol—Hyperhidrosis—Mesalazine—Crohn's disease	0.0108	0.0121	CcSEcCtD
Penbutolol—Insomnia—Mesalazine—Crohn's disease	0.0101	0.0113	CcSEcCtD
Penbutolol—Dyspnoea—Mesalazine—Crohn's disease	0.00996	0.0111	CcSEcCtD
Penbutolol—Dyspepsia—Mesalazine—Crohn's disease	0.00984	0.011	CcSEcCtD
Penbutolol—Body temperature increased—Azathioprine—Crohn's disease	0.0097	0.0108	CcSEcCtD
Penbutolol—Fatigue—Mesalazine—Crohn's disease	0.00964	0.0108	CcSEcCtD
Penbutolol—Erectile dysfunction—Prednisone—Crohn's disease	0.00958	0.0107	CcSEcCtD
Penbutolol—Pain—Mesalazine—Crohn's disease	0.00956	0.0107	CcSEcCtD
Penbutolol—Depression—Prednisone—Crohn's disease	0.00925	0.0103	CcSEcCtD
Penbutolol—Body temperature increased—Mesalazine—Crohn's disease	0.00884	0.00986	CcSEcCtD
Penbutolol—Bradycardia—Prednisone—Crohn's disease	0.00847	0.00946	CcSEcCtD
Penbutolol—Diarrhoea—Azathioprine—Crohn's disease	0.0084	0.00937	CcSEcCtD
Penbutolol—Dizziness—Azathioprine—Crohn's disease	0.00811	0.00905	CcSEcCtD
Penbutolol—Asthenia—Mesalazine—Crohn's disease	0.00802	0.00895	CcSEcCtD
Penbutolol—Headache—Azathioprine—Crohn's disease	0.00769	0.00858	CcSEcCtD
Penbutolol—Diarrhoea—Mesalazine—Crohn's disease	0.00765	0.00853	CcSEcCtD
Penbutolol—Dizziness—Mesalazine—Crohn's disease	0.00739	0.00825	CcSEcCtD
Penbutolol—Alopecia—Prednisone—Crohn's disease	0.00736	0.00821	CcSEcCtD
Penbutolol—Nausea—Azathioprine—Crohn's disease	0.00729	0.00813	CcSEcCtD
Penbutolol—Headache—Mesalazine—Crohn's disease	0.007	0.00781	CcSEcCtD
Penbutolol—Nausea—Mesalazine—Crohn's disease	0.00664	0.00741	CcSEcCtD
Penbutolol—Hyperhidrosis—Prednisone—Crohn's disease	0.00572	0.00638	CcSEcCtD
Penbutolol—Insomnia—Prednisone—Crohn's disease	0.00535	0.00597	CcSEcCtD
Penbutolol—Dyspepsia—Prednisone—Crohn's disease	0.00521	0.00581	CcSEcCtD
Penbutolol—Fatigue—Prednisone—Crohn's disease	0.0051	0.00569	CcSEcCtD
Penbutolol—Body temperature increased—Prednisone—Crohn's disease	0.00467	0.00522	CcSEcCtD
Penbutolol—Asthenia—Prednisone—Crohn's disease	0.00424	0.00473	CcSEcCtD
Penbutolol—Diarrhoea—Prednisone—Crohn's disease	0.00405	0.00451	CcSEcCtD
Penbutolol—Dizziness—Prednisone—Crohn's disease	0.00391	0.00436	CcSEcCtD
Penbutolol—Headache—Prednisone—Crohn's disease	0.0037	0.00413	CcSEcCtD
Penbutolol—Nausea—Prednisone—Crohn's disease	0.00351	0.00392	CcSEcCtD
Penbutolol—HTR1A—G alpha (i) signalling events—CCR9—Crohn's disease	0.000908	0.00874	CbGpPWpGaD
Penbutolol—ADRB2—G alpha (s) signalling events—PTGER4—Crohn's disease	0.000903	0.00869	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000881	0.00848	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000881	0.00848	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—ACKR2—Crohn's disease	0.000875	0.00842	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000862	0.0083	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—ACKR2—Crohn's disease	0.000856	0.00824	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000843	0.00811	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—ACKR2—Crohn's disease	0.000837	0.00805	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—MLN—Crohn's disease	0.000829	0.00798	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000819	0.00788	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—MLN—Crohn's disease	0.000811	0.00781	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000801	0.00771	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—MLN—Crohn's disease	0.000793	0.00764	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—CCR6—Crohn's disease	0.000789	0.0076	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000783	0.00754	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000755	0.00727	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000738	0.00711	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000733	0.00705	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000722	0.00695	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CCR9—Crohn's disease	0.000722	0.00695	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000702	0.00676	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000686	0.00661	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000671	0.00646	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—GPR65—Crohn's disease	0.000671	0.00646	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000645	0.00621	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000628	0.00604	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—CCR6—Crohn's disease	0.000601	0.00579	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—MLN—Crohn's disease	0.000588	0.00566	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000583	0.00562	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CCR9—Crohn's disease	0.000575	0.00553	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000571	0.0055	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—ACKR2—Crohn's disease	0.000564	0.00543	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CCR9—Crohn's disease	0.000562	0.00541	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000558	0.00537	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000553	0.00532	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CCR9—Crohn's disease	0.00055	0.00529	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—GPR65—Crohn's disease	0.000534	0.00514	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—MLN—Crohn's disease	0.000534	0.00514	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—GPR65—Crohn's disease	0.000523	0.00503	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000514	0.00495	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—GPR65—Crohn's disease	0.000511	0.00492	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000503	0.00484	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.0005	0.00481	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.000492	0.00474	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000491	0.00473	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000489	0.00471	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000478	0.0046	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CCR6—Crohn's disease	0.000478	0.0046	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—MLN—Crohn's disease	0.000469	0.00451	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—MLN—Crohn's disease	0.000458	0.00441	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—ACKR2—Crohn's disease	0.000449	0.00432	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—MLN—Crohn's disease	0.000448	0.00432	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00044	0.00424	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—ACKR2—Crohn's disease	0.000439	0.00423	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000431	0.00415	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—ACKR2—Crohn's disease	0.000429	0.00413	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—MLN—Crohn's disease	0.000425	0.0041	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000421	0.00405	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—PTGER4—Crohn's disease	0.000421	0.00405	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—MLN—Crohn's disease	0.000416	0.00401	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CCR9—Crohn's disease	0.000408	0.00393	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—MLN—Crohn's disease	0.000407	0.00392	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CCR6—Crohn's disease	0.000381	0.00367	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—GPR65—Crohn's disease	0.000379	0.00365	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CCR6—Crohn's disease	0.000372	0.00359	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCR9—Crohn's disease	0.00037	0.00357	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CCR6—Crohn's disease	0.000364	0.00351	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—GPR65—Crohn's disease	0.000344	0.00331	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—PTGER4—Crohn's disease	0.000335	0.00323	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ACKR2—Crohn's disease	0.000333	0.00321	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—PTGER4—Crohn's disease	0.000328	0.00316	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CCR9—Crohn's disease	0.000325	0.00313	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—PTGER4—Crohn's disease	0.000321	0.00309	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CCR9—Crohn's disease	0.000318	0.00306	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MLN—Crohn's disease	0.000316	0.00304	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CCR9—Crohn's disease	0.000311	0.00299	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—GPR65—Crohn's disease	0.000302	0.00291	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—GPR65—Crohn's disease	0.000295	0.00284	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCR9—Crohn's disease	0.000295	0.00284	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—GPR65—Crohn's disease	0.000289	0.00278	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TAGAP—Crohn's disease	0.000289	0.00278	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCR9—Crohn's disease	0.000289	0.00278	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCR9—Crohn's disease	0.000282	0.00272	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—GPR65—Crohn's disease	0.000274	0.00264	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CCR6—Crohn's disease	0.00027	0.0026	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000269	0.00259	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—GPR65—Crohn's disease	0.000268	0.00258	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ACKR2—Crohn's disease	0.000265	0.00255	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—GPR65—Crohn's disease	0.000262	0.00253	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ACKR2—Crohn's disease	0.000259	0.0025	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000258	0.00248	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000254	0.00245	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ACKR2—Crohn's disease	0.000254	0.00244	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RSPO3—Crohn's disease	0.000252	0.00243	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MLN—Crohn's disease	0.000251	0.00242	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MLN—Crohn's disease	0.000246	0.00237	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCR6—Crohn's disease	0.000245	0.00236	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MLN—Crohn's disease	0.00024	0.00231	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SEL1L—Crohn's disease	0.000239	0.0023	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—PTGER4—Crohn's disease	0.000238	0.00229	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TAGAP—Crohn's disease	0.00023	0.00221	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TAGAP—Crohn's disease	0.000225	0.00217	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TAGAP—Crohn's disease	0.00022	0.00212	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCR9—Crohn's disease	0.000219	0.00211	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—PTGER4—Crohn's disease	0.000216	0.00208	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CCR6—Crohn's disease	0.000215	0.00207	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CCR6—Crohn's disease	0.00021	0.00203	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CCR6—Crohn's disease	0.000206	0.00198	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—GPR65—Crohn's disease	0.000203	0.00196	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—IL3—Crohn's disease	0.000203	0.00195	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000202	0.00195	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RSPO3—Crohn's disease	0.000201	0.00193	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RSPO3—Crohn's disease	0.000197	0.00189	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000196	0.00189	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCR6—Crohn's disease	0.000195	0.00188	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000194	0.00187	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RSPO3—Crohn's disease	0.000192	0.00185	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCR6—Crohn's disease	0.000191	0.00184	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SEL1L—Crohn's disease	0.00019	0.00183	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000189	0.00182	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000187	0.0018	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCR6—Crohn's disease	0.000187	0.0018	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SEL1L—Crohn's disease	0.000186	0.00179	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000185	0.00178	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL3—Crohn's disease	0.000184	0.00177	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SEL1L—Crohn's disease	0.000182	0.00175	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000181	0.00174	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—RASGRP1—Crohn's disease	0.000178	0.00171	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCR9—Crohn's disease	0.000174	0.00168	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PTGER4—Crohn's disease	0.000172	0.00166	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCR9—Crohn's disease	0.00017	0.00164	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PTGER4—Crohn's disease	0.000168	0.00162	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCR9—Crohn's disease	0.000167	0.0016	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PTGER4—Crohn's disease	0.000165	0.00158	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GPR65—Crohn's disease	0.000162	0.00156	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—IL3—Crohn's disease	0.000161	0.00155	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000161	0.00155	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GPR65—Crohn's disease	0.000158	0.00153	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—IL3—Crohn's disease	0.000158	0.00152	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000158	0.00152	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000156	0.0015	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GPR65—Crohn's disease	0.000155	0.00149	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—IL3—Crohn's disease	0.000154	0.00149	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000154	0.00148	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CXCL8—Crohn's disease	0.000154	0.00148	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000153	0.00147	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000151	0.00145	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000149	0.00144	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL3—Crohn's disease	0.000147	0.00141	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCR6—Crohn's disease	0.000145	0.0014	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL3—Crohn's disease	0.000143	0.00138	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—IL2RA—Crohn's disease	0.000142	0.00137	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000142	0.00136	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL3—Crohn's disease	0.00014	0.00135	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000139	0.00133	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000136	0.0013	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RBX1—Crohn's disease	0.000131	0.00126	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL2RA—Crohn's disease	0.000129	0.00124	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PTGER4—Crohn's disease	0.000128	0.00123	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CXCL8—Crohn's disease	0.000123	0.00118	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CXCL8—Crohn's disease	0.00012	0.00116	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CXCL8—Crohn's disease	0.000117	0.00113	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCR6—Crohn's disease	0.000115	0.00111	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—UBE2D1—Crohn's disease	0.000115	0.00111	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000113	0.00109	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCR6—Crohn's disease	0.000113	0.00109	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RIPK2—Crohn's disease	0.000111	0.00107	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000111	0.00106	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCR6—Crohn's disease	0.00011	0.00106	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL3—Crohn's disease	0.000109	0.00105	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000108	0.00104	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RASGRP1—Crohn's disease	0.000105	0.00101	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RBX1—Crohn's disease	0.000104	0.001	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL2RA—Crohn's disease	0.000103	0.000988	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RBX1—Crohn's disease	0.000102	0.000983	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PTGER4—Crohn's disease	0.000102	0.000978	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL2RA—Crohn's disease	0.0001	0.000967	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RBX1—Crohn's disease	9.98e-05	0.000961	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PTGER4—Crohn's disease	9.94e-05	0.000957	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL2RA—Crohn's disease	9.82e-05	0.000945	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PTGER4—Crohn's disease	9.72e-05	0.000936	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—JAK2—Crohn's disease	9.54e-05	0.000918	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SOCS1—Crohn's disease	9.52e-05	0.000917	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—UBE2D1—Crohn's disease	9.15e-05	0.000881	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—TYK2—Crohn's disease	9.08e-05	0.000874	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—UBE2D1—Crohn's disease	8.95e-05	0.000862	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RIPK2—Crohn's disease	8.87e-05	0.000854	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—UBE2D1—Crohn's disease	8.75e-05	0.000843	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CXCL8—Crohn's disease	8.7e-05	0.000838	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RIPK2—Crohn's disease	8.68e-05	0.000836	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—JAK2—Crohn's disease	8.66e-05	0.000834	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL3—Crohn's disease	8.65e-05	0.000833	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RIPK2—Crohn's disease	8.49e-05	0.000817	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL3—Crohn's disease	8.47e-05	0.000815	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RASGRP1—Crohn's disease	8.37e-05	0.000806	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL3—Crohn's disease	8.28e-05	0.000797	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SMAD3—Crohn's disease	8.22e-05	0.000792	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RASGRP1—Crohn's disease	8.19e-05	0.000788	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	8.01e-05	0.000771	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CXCL8—Crohn's disease	7.9e-05	0.000761	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL2RA—Crohn's disease	7.61e-05	0.000733	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	7.6e-05	0.000731	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	7.58e-05	0.00073	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—JAK2—Crohn's disease	7.43e-05	0.000715	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SOCS1—Crohn's disease	7.42e-05	0.000714	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	7.27e-05	0.0007	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	7.25e-05	0.000698	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	7.23e-05	0.000696	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—TYK2—Crohn's disease	7.07e-05	0.000681	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	6.93e-05	0.000667	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	6.92e-05	0.000666	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	6.9e-05	0.000664	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCL8—Crohn's disease	6.78e-05	0.000653	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—JAK2—Crohn's disease	6.75e-05	0.00065	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	6.63e-05	0.000638	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	6.6e-05	0.000635	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	6.55e-05	0.00063	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SMAD3—Crohn's disease	6.4e-05	0.000617	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	6.3e-05	0.000606	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	6.26e-05	0.000603	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCL8—Crohn's disease	6.16e-05	0.000593	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	6.06e-05	0.000584	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	6.02e-05	0.00058	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL2RA—Crohn's disease	5.93e-05	0.000571	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	5.8e-05	0.000558	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TYK2—Crohn's disease	5.36e-05	0.000516	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—JAK2—Crohn's disease	5.12e-05	0.000493	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	4.67e-05	0.00045	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL6—Crohn's disease	4.44e-05	0.000428	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TYK2—Crohn's disease	4.27e-05	0.000411	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TYK2—Crohn's disease	4.18e-05	0.000402	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TYK2—Crohn's disease	4.09e-05	0.000393	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—JAK2—Crohn's disease	4.07e-05	0.000392	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—JAK2—Crohn's disease	3.99e-05	0.000384	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—JAK2—Crohn's disease	3.9e-05	0.000375	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—STAT3—Crohn's disease	3.76e-05	0.000362	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	3.72e-05	0.000358	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCL8—Crohn's disease	3.64e-05	0.00035	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	3.56e-05	0.000343	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL6—Crohn's disease	3.54e-05	0.00034	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6—Crohn's disease	3.46e-05	0.000333	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6—Crohn's disease	3.38e-05	0.000326	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—STAT3—Crohn's disease	2.99e-05	0.000288	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—STAT3—Crohn's disease	2.93e-05	0.000282	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—STAT3—Crohn's disease	2.86e-05	0.000275	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6—Crohn's disease	2.62e-05	0.000253	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6—Crohn's disease	2.09e-05	0.000201	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6—Crohn's disease	2.04e-05	0.000197	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6—Crohn's disease	2e-05	0.000192	CbGpPWpGaD
